Droplet Biosciences uses lymph fluid and NVIDIA Parabricks to detect residual cancer faster and cut analysis time and costs.

CAMBRIDGE, Mass., March 3, 2026 /PRNewswire/ -- Droplet Biosciences, a diagnostics company pioneering lymph-based liquid biopsy testing, today announced that it is dramatically reducing genomic ...

Study finds little agreement across 21 direct-to-consumer tests ...

A new tool enables biomedical researchers from around the world to quickly see the connections between lipids and proteins inside cells, thanks to a new initiative led by scientists at Oregon Health & ...

The day we discovered that our then 15-month-old baby was one of just 200 people in the world with a genetic brain condition will be for ever etched on my mind.

Emerging mass spectrometry technologies integrating ion mobility, TIMS–PASEF, and real-time search are enhancing sensitivity, ...

OHSU scientists lead development of so-called 'Google maps' for how lipids interact with proteins inside cells OHSU scientists Fikadu ...

Vladimir Putin took part in the plenary session of the Future Technologies Forum. The discussion theme is Bioeconomy for ...

Beef has yet again become a hot potato in Kerala. Well-marinated with political masala, of course. The beef debate raged some ...

The human lymphatic system is notoriously difficult to map due to its size and variability among individuals. Spatial ...

NeoGenomics announced the launch of RaDaR® ST, its circulating tumor DNA assay for detecting molecular residual disease.

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo") today announced its results for the fourth quarter and full year ended December 31, 2025. The update, including a webcast slide presentation with ...